← Leaderboards
Peter J Gruber
Children'S Hosp Of Philadelphia
$2,227,267
Attributed
$3,659,390
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $449.3K · FY2011–24$500K$375K$250K$125K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,659,390 · 2
By mechanism
U01$2,148,185 · 1
R01$1,511,205 · 1
Top collaborators
- Martina Brueckner5 shared
- Richard P Lifton5 shared
Most similar at Children'S Hosp Of Philadelphia
Same institution · by research overlap
- Robert J Levy$36,673,646
- James William Gaynor$5,405,569
- Mark A Fogel$9,747,154
- Stephen Paridon$1,749,233
- Joseph W Rossano$2,634,008
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacBaseCost EffectiveCommunitiesCongenital AbnormalityCopy Number PolymorphismAffectChromatinClinical CareCommon VentricleComplexComputerized Medical RecordCancer RiskChargeCodeChromatin RemodelingChromatin Remodeling FactorCiliaComorbidityClinical DataAneuploidyCohortAdultCosts And Benefits
Grant awards (10)
Congenital Heart Disease Genetics and Clinical Outcomes$420,644
U01 · FY2024 · HL
Congenital Heart Disease Genetics and Clinical Outcomes$425,287
U01 · FY2023 · HL
Congenital Heart Disease Genetics and Clinical Outcomes$426,094
U01 · FY2022 · HL
Congenital Heart Disease Genetics and Clinical Outcomes$426,876
U01 · FY2021 · HL
Congenital Heart Disease Genetics and Clinical Outcomes$449,284
U01 · FY2020 · HL
Histone deacetylase-mediated reduction of ischemia-reperfusion injury$297,470
R01 · FY2015 · HL · contact PI
Histone deacetylase-mediated reduction of ischemia-reperfusion injury$295,960
R01 · FY2014 · HL · contact PI
Histone deacetylase-mediated reduction of ischemia-reperfusion injury$283,775
R01 · FY2013 · HL · contact PI
Histone deacetylase-mediated reduction of ischemia-reperfusion injury$299,000
R01 · FY2012 · HL · contact PI
Histone deacetylase-mediated reduction of ischemia-reperfusion injury$335,000
R01 · FY2011 · HL · contact PI